September 12, 2007 — BD Diagnostics announced that it has made a 510(k) submission to the FDA for additional claims for the BD GeneOhm StaphSR assay.
This will be the first assay for rapid and simultaneous identification of Staphylococcus aureus (SA) and methicillin-resistant Staphylococcus aureus (MRSA) from patients colonized in the nasal passage.